Cargando…
IgM exacerbates glomerular disease progression in complement induced glomerulopathy
While glomerular IgM deposition occurs in a variety of glomerular diseases the mechanism of deposition and its clinical significance remain controversial. Some have theorized IgM becomes passively trapped in areas of glomerulosclerosis. However, recent studies found that IgM specifically binds damag...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556608/ https://www.ncbi.nlm.nih.gov/pubmed/25945405 http://dx.doi.org/10.1038/ki.2015.120 |
_version_ | 1782388362585309184 |
---|---|
author | Panzer, Sarah E. Laskowski, Jennifer Renner, Brandon Kulik, Liudmila Ljubanovic, Danica Huber, Kendra M. Zhong, Weixiong Pickering, Matthew C. Holers, V. Michael Thurman, Joshua M. |
author_facet | Panzer, Sarah E. Laskowski, Jennifer Renner, Brandon Kulik, Liudmila Ljubanovic, Danica Huber, Kendra M. Zhong, Weixiong Pickering, Matthew C. Holers, V. Michael Thurman, Joshua M. |
author_sort | Panzer, Sarah E. |
collection | PubMed |
description | While glomerular IgM deposition occurs in a variety of glomerular diseases the mechanism of deposition and its clinical significance remain controversial. Some have theorized IgM becomes passively trapped in areas of glomerulosclerosis. However, recent studies found that IgM specifically binds damaged glomeruli. Therefore, we tested whether natural IgM binds to neo-epitopes exposed after insults to the glomerulus and exacerbate disease in mice deficient in the complement regulatory protein factor H; a model of non-sclerotic and nonimmune-complex glomerular disease. Immunofluorescence microscopy demonstrated mesangial and capillary loop deposition of IgM while ultrastructural analysis found IgM deposition on endothelial cells and subendothelial areas. Factor H deficient mice lacking B cells were protected from renal damage, as evidenced by milder histologic lesions on light and electron microscopy. IgM, but not IgG, from wild-type mice bound to cultured murine mesangial cells. Furthermore, injection of purified IgM into mice lacking B cells bound within the glomeruli and induced proteinuria. A monoclonal natural IgM recognizing phospholipids also bound to glomeruli in vivo and induced albuminuria. Thus, our results indicate specific IgM antibodies bind to glomerular epitopes and that IgM contributes to the progression of glomerular damage in this mouse model of non-sclerotic glomerular disease. |
format | Online Article Text |
id | pubmed-4556608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-45566082016-03-01 IgM exacerbates glomerular disease progression in complement induced glomerulopathy Panzer, Sarah E. Laskowski, Jennifer Renner, Brandon Kulik, Liudmila Ljubanovic, Danica Huber, Kendra M. Zhong, Weixiong Pickering, Matthew C. Holers, V. Michael Thurman, Joshua M. Kidney Int Article While glomerular IgM deposition occurs in a variety of glomerular diseases the mechanism of deposition and its clinical significance remain controversial. Some have theorized IgM becomes passively trapped in areas of glomerulosclerosis. However, recent studies found that IgM specifically binds damaged glomeruli. Therefore, we tested whether natural IgM binds to neo-epitopes exposed after insults to the glomerulus and exacerbate disease in mice deficient in the complement regulatory protein factor H; a model of non-sclerotic and nonimmune-complex glomerular disease. Immunofluorescence microscopy demonstrated mesangial and capillary loop deposition of IgM while ultrastructural analysis found IgM deposition on endothelial cells and subendothelial areas. Factor H deficient mice lacking B cells were protected from renal damage, as evidenced by milder histologic lesions on light and electron microscopy. IgM, but not IgG, from wild-type mice bound to cultured murine mesangial cells. Furthermore, injection of purified IgM into mice lacking B cells bound within the glomeruli and induced proteinuria. A monoclonal natural IgM recognizing phospholipids also bound to glomeruli in vivo and induced albuminuria. Thus, our results indicate specific IgM antibodies bind to glomerular epitopes and that IgM contributes to the progression of glomerular damage in this mouse model of non-sclerotic glomerular disease. 2015-05-06 2015-09 /pmc/articles/PMC4556608/ /pubmed/25945405 http://dx.doi.org/10.1038/ki.2015.120 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Panzer, Sarah E. Laskowski, Jennifer Renner, Brandon Kulik, Liudmila Ljubanovic, Danica Huber, Kendra M. Zhong, Weixiong Pickering, Matthew C. Holers, V. Michael Thurman, Joshua M. IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title | IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title_full | IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title_fullStr | IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title_full_unstemmed | IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title_short | IgM exacerbates glomerular disease progression in complement induced glomerulopathy |
title_sort | igm exacerbates glomerular disease progression in complement induced glomerulopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556608/ https://www.ncbi.nlm.nih.gov/pubmed/25945405 http://dx.doi.org/10.1038/ki.2015.120 |
work_keys_str_mv | AT panzersarahe igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT laskowskijennifer igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT rennerbrandon igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT kulikliudmila igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT ljubanovicdanica igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT huberkendram igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT zhongweixiong igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT pickeringmatthewc igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT holersvmichael igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy AT thurmanjoshuam igmexacerbatesglomerulardiseaseprogressionincomplementinducedglomerulopathy |